-+ 0.00%
-+ 0.00%
-+ 0.00%

BIOHAVEN AND SK BIOPHARMACEUTICALS ENTER INTO STRATEGIC GLOBAL LICENSING AGREEMENT FOR NOVEL KV7 ION CHANNEL PLATFORM AND OPAKALIM, LEAD CANDIDATE FOR EPILEPSY

Reuters·08/26/2026 06:36:59

Please log in to view news